GAP Protecting Group Synthesis via Grignard Substitution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing Group-Assisted Purification (GAP) protecting groups, such as benzyl diphenylphosphine oxide (HOBnDpp), are inefficient due to the need for extreme temperature control, use of dangerous reagents like butyllithium, and production of problematic byproducts like manganese dioxide, making them unsuitable for scalable and safe commercial production.

Innovation Solution

A novel synthesis method that avoids oxidation, esterification, and reduction steps by using protected 4-bromobenzylalcohol and Grignard reagents, eliminating the need for pyrophoric butyllithium and reducing the formation of hazardous byproducts, thereby improving the scalability and safety of HOBnDpp synthesis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional methods using butyllithium and oxidation are employed to synthesize HOBnDpp, then the protecting group can be formed, but the process requires extreme temperature control, uses dangerous reagents, and produces problematic byproducts

Engineering Contradiction:
ImprovesafetyVSAvoidsynthesis process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent removes the hazardous butyllithium reagent from the synthesis pathway and replaces it with a Grignard reagent system. This extraction of the dangerous component eliminates the need for extreme temperature control (-80°C) while maintaining the core synthetic function of forming the carbon-phosphorus bond in HOBnDpp.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention employs readily available starting materials (4-bromobenzyl alcohol, magnesium, diphenylchlorophosphine) that can be handled under常规 conditions rather than requiring specialized equipment for pyrophoric reagents. The Grignard reagent system uses inexpensive, stable components that eliminate the need for complex temperature control infrastructure.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Manufacturing precision

If oxidation with potassium permanganate is used to produce HOBnDpp, then the phosphine oxide group is formed, but manganese dioxide byproduct is generated which requires centrifugation or fine filtration

Engineering Contradiction:
Improvepurification qualityVSAvoidscalability
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent extracts the oxidation step from the synthesis pathway entirely. Instead of using potassium permanganate oxidation to form the phosphine oxide group, the method employs diphenylchlorophosphine which directly introduces the phosphine oxide functionality through nucleophilic substitution, eliminating manganese dioxide byproduct formation.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention achieves the same molecular transformation (formation of phosphine oxide group) through a different chemical mechanism that produces cleaner results. The Grignard reagent followed by diphenylchlorophosphine substitution copies the functional outcome of oxidation without the harmful byproducts, enabling simpler purification.

Inventive Principle:
Principle #26Copying

3Manufacturing precision

If multiple synthesis steps including oxidation, esterification, and reduction are used to create HOBnDpp, then the protecting group structure is achieved, but the synthesis time and complexity increase

Engineering Contradiction:
Improvestructural accuracyVSAvoidsynthesis efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent merges multiple synthetic operations into a streamlined sequence. The Grignard formation and subsequent substitution with diphenylchlorophosphine combine what would traditionally require separate oxidation, esterification, and reduction steps into a direct two-step process, reducing overall synthesis time while maintaining structural accuracy.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention performs preliminary protection of the alcohol group as a silyl ether before the main transformation, preventing side reactions during the Grignard formation and substitution. This preliminary action simplifies the overall pathway by avoiding the need for subsequent deprotection and re-protection steps that would increase synthesis time.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly reduces synthesis time and complexity, enhances safety, and allows for the scalable production of GAP protecting groups, facilitating more efficient and cost-effective GAP peptide synthesis.

Implementation Method 1

forming a Grignard reagent, adding the Grignard reagent to diphenylchlorophosphine

Methodology Applied
Scientific EffectGrignard reaction: Chemical Bonding

Implementation Method 2

oxidizing the phosphine with hydrogen peroxide to form the phosphine oxide

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

removing the TMS with 2M HCl (aq)

Methodology Applied
Scientific EffectAcid-catalyzed deprotection: Chemical Bonding

Data Source

PatentUS11827660B2Synthesis strategy for gap protecting group
Publication Date: 2023.11.28 SEDERMA SA
  • US11827660B2 patent drawing
  • US11827660B2 patent drawing
  • US11827660B2 patent drawing

AI summary

The present invention relates to a novel synthesis method to form particular molecules. These molecules have multiple uses, most notably in the field of protecting groups used throughout organic and synthetic chemistry. The disclosed method is safer, more cost- and time-effective, and more amenable to large scale production than those currently known in the art. The protecting groups synthesized are useful in GAP peptide synthesis.